CXCR2 and hepatocellular carcinoma: used Glypican‐3 (GPC3) CAR‐T cells expressing CXCR2 (CXCR2 CAR‐T) to treat hepatocellular carcinoma which showed relatively high expressions of several CXCR2 ligands.